Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial
Authors:
- Yun ZouYZYun Zou
- Shih-Jen ChangSCShih-Jen Chang
- Yajing QiuYQYajing Qiu
- Hui ChenHCHui Chen
- Ma GangMGMa Gang
- Yunbo JinYJYunbo Jin
- Xiaoxi LinXLXiaoxi Lin
- 1 March 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 141 (3) , 646-650
Abstract
Background: Early intervention might improve the quality of surgical scars. Botulinum toxin type A has been shown to improve surgical scars in the past decade. The purpose of this study was to evaluate the effect of botulinum toxin type A on surgical facial scars. Methods: In this prospective, split-scar, double-blind, randomized controlled trial, 16 consecutive patients who underwent facial surgery between June and October of 2015 were enrolled. Botulinum toxin type A was injected randomly into half of each surgical wound closure immediately after surgery. The scars were assessed independently by two plastic surgeons at a 6-month follow-up visit using the Vancouver Scar Scale and the visual analogue scale. The scar width was also measured. Results: Fourteen patients completed the study. The visual analogue scale score and scar width measurements revealed a significant improvement in appearance and narrower scars for the botulinum toxin type A–treated halves of the scars (p = 0.046 and p = 0.001, respectively). The mean Vancouver Scar Scale score was 4.68 for the botulinum toxin type A–injected group and 5.24 for the control group (p = 0.15). In addition, the Vancouver Scar Scale height score was significantly different between the two groups (p = 0.008). Conclusion: This study demonstrates that early postsurgical botulinum toxin injections can produce better, narrower, and flatter facial surgical scars. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.Keywords
This publication has 16 references indexed in Scilit:
- A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasmJournal of the Neurological Sciences, 2016
- The Use of Botulinum Toxin in the Management of Headache DisordersSeminars in Neurology, 2016
- Focal hyperhidrosis secondary to eccrine naevus successfully treated with botulinum toxin type AClinical and Experimental Dermatology, 2015
- Botulinum Toxin to Improve Results in Cleft Lip RepairPlastic and Reconstructive Surgery, 2014
- Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split‐scar, double‐blind randomized controlled trialWound Repair and Regeneration, 2014
- Consensus Recommendations on the Aesthetic Usage of Botulinum Toxin Type A in AsiansDermatologic Surgery, 2013
- Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised studyJournal of Plastic, Reconstructive & Aesthetic Surgery, 2013
- Current Methods Employed in the Prevention and Minimization of Surgical ScarsDermatologic Surgery, 2011
- Botulinum Toxin to Improve Facial Wound Healing: A Prospective, Blinded, Placebo-Controlled StudyMayo Clinic Proceedings, 2006
- Treatment of Facial Wounds with Botulinum Toxin A Improves Cosmetic Outcome in Primates by Holger G. Gassner, M.D., David A. Sherris, M.D., and Clark C. Otley, M.D.Plastic and Reconstructive Surgery, 2000